# FDA Inspection 1018313 - Conceptions- SkyRidge - June 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/conceptions-skyridge/50437387-9077-46c1-bec9-5939c68c19e3
Source feed: FDA_Inspections

> FDA Inspection 1018313 for Conceptions- SkyRidge on June 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018313
- Company Name: Conceptions- SkyRidge
- Inspection Date: 2017-06-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1115363 - 2019-12-05](https://www.keypedia.com/records/fda_inspections/conceptions-skyridge/62c6b8c1-eb55-4b6c-86c5-2804aa48aff0)
- [FDA Inspection 902236 - 2014-11-03](https://www.keypedia.com/records/fda_inspections/conceptions-skyridge/ee97f957-fd06-40a4-bc72-7b49a472e79e)

Company: https://www.keypedia.com/companies/conceptions-skyridge/65be538e-ecaa-4178-8eae-a294dfed1100

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d